Skip to Main Content

Paper Details

New scaffolds for type II JAK2 inhibitors overcome the acquired G993A resistance mutation.
Cell Chem Biol
1
2023
Author NameAffiliation
David M WeinstockDana-Farber Cancer Institute, Broad Institute of MIT and Harvard, Harvard Medical School
  • 1 - 1

Datasets

Release 1.2